Randomized, Double-blind, Placebo-controlled, Multicenter, Cross-over Study to Assess the Effects of a 3 Week Therapy Each With QVA149 Versus Placebo on Pulmonary Function and Average Physical Activity Levels in Patients With COPD.
Clinical trial NCT01996319 · COMPLETED
Trial details
- NCT number
- NCT01996319
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2015-02-01
- Enrollment
- 194
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.